BONAVITA, SIMONA
 Distribuzione geografica
Continente #
NA - Nord America 105
AS - Asia 104
EU - Europa 47
SA - Sud America 31
AF - Africa 3
Totale 290
Nazione #
US - Stati Uniti d'America 104
SG - Singapore 40
BR - Brasile 25
CN - Cina 23
VN - Vietnam 21
DE - Germania 15
IT - Italia 10
IN - India 9
FI - Finlandia 8
SE - Svezia 7
EC - Ecuador 3
GB - Regno Unito 3
CZ - Repubblica Ceca 2
HK - Hong Kong 2
TH - Thailandia 2
ZA - Sudafrica 2
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CA - Canada 1
CO - Colombia 1
ES - Italia 1
IQ - Iraq 1
JO - Giordania 1
KR - Corea 1
MA - Marocco 1
MY - Malesia 1
PY - Paraguay 1
SA - Arabia Saudita 1
UA - Ucraina 1
Totale 290
Città #
Singapore 19
San Jose 18
Munich 14
Ashburn 10
Turku 8
Ho Chi Minh City 7
Dallas 6
Bengaluru 5
Chandler 5
Hefei 5
Lawrence 5
Princeton 5
Santa Clara 5
Milan 4
Xian 4
Beijing 3
London 3
Wilmington 3
Augusta 2
Bangkok 2
Biên Hòa 2
Brasília 2
Chicago 2
Des Moines 2
Hanoi 2
Hong Kong 2
Olomouc 2
Quito 2
Amman 1
Angra dos Reis 1
Barretos 1
Basīrhat 1
Bình An 1
Cao Lanh 1
Cape Town 1
Carmópolis de Minas 1
Casablanca 1
Clearwater 1
Colorado 1
Columbus 1
Criciúma 1
Curitiba 1
Da Nang 1
Erbil 1
Exu 1
Fremont 1
Grand Rapids 1
Greensboro 1
Ha Long 1
Hanover 1
Itapemirim 1
Jaboatão dos Guararapes 1
Jeddah 1
Johannesburg 1
Juiz de Fora 1
Juneau 1
Kuala Selangor 1
Leawood 1
Long An 1
Luque 1
Maceió 1
Medellín 1
Mississauga 1
New York 1
Nova Friburgo 1
Orem 1
Pamplona 1
Parobé 1
Phú Thọ 1
Posadas 1
Redwood City 1
Rio de Janeiro 1
Salto 1
Salvador 1
San Francisco 1
Secaucus 1
Seoul 1
Shanghai 1
Sigsig 1
Sorriso 1
Surat 1
São José da Bela Vista 1
São João de Meriti 1
São Paulo 1
São Sebastião 1
Taboão da Serra 1
The Dalles 1
Thái Nguyên 1
Tây Ninh 1
Uberlândia 1
Yevlakh 1
Yên Bái 1
Totale 213
Nome #
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 75
Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: A 18-month multicentre study 66
Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis 58
Genetic association of α2-macroglobulin polymorphisms with AD in southern Italy 55
PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective study 44
Totale 298
Categoria #
all - tutte 2.536
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.536


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202217 0 0 0 5 2 0 1 4 0 3 2 0
2022/202322 10 0 3 1 2 1 0 1 1 1 2 0
2023/202420 4 4 4 1 1 4 0 0 0 0 1 1
2024/202559 9 1 1 0 5 7 1 0 6 2 12 15
2025/2026158 13 17 26 33 18 7 9 4 21 4 6 0
Totale 298